MTOR and tuberous sclerosis: In mouse models of Tuberous Sclerosis Complex (TSC), where mTOR pathway hyperactivation is a hallmark, rapamycin prevented seizures, reduced mortality, and rescued neuropathology (i.e., glial proliferation and disrupted cortical architecture).